Abstract

Obesity these days had become a major health problem with prevalence both in developed as well as in developing countries. Overweight and obese children are likely to stay obese into adulthood [1]. While overweight and obesity are themselves risk factors to develop non communicable diseases like diabetes and cardiovascular diseases (CVD) at younger age, their association with metabolic dysregulation further increases the risk. The objective of this article is to identify the causes of obesity, to highlight its association with metabolic dysregulation and to suggest ways to prevent it, so as decrease co-morbidities associated with it.

Keywords: Overweight; Obesity; Metabolic Dysregulation; BMI

References

1. Singh AS., et al. “Tracking of childhood overweight into adulthood: a systematic review of the literature”. Obesity Reviews 5 (2008): 474-488.
2. Barlow SE and Expert C. “Expert committee recommendations regarding the prevalence, assessment, and treatment of child and adolescent overweight and obesity: summary report”. Pediatrics4 (2007): S164-S192.
3. Khadilkar V., et al. “Body Mass Index Cut-offs for screening for Childhood Overweight and Obesity in Indian Children”. Indian Pediatrics 49 (2012): 29-34.
4. Church TS., et al. “Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity”. PLoS One5 (2011): e19657.
5. Huang PL. “A comprehensive definition of metabolic syndrome”. Disease Models and Mechanisms 2 (2009): 231-237.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)”. The Journal of the American Medical Association 285 (2001): 2486-2497.
7. Kanneganti TD and Dixit VD. “Immunological complications of obesity”. Nature Immunology 13 (2012): 707-712.
8. Yang Youm YH., et al. “Obesity accelerates thymic aging”. Blood 114 (2009): 3803-3812.
9. Karlsson EA., et al. “Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells”. Journal of Nutrition 140 (2010): 169-167.
10. Guilherme A., et al. “Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes”. Nature Reviews Molecular Cell Biology 9 (2008): 367-377.
11. Andersen CJ and Fernandez ML. “Dietary approaches to improving atheroprotective HDL functions”. Food and Function 4 (2013): 1304-1313.
12. Levine DM., et al. “In vivo protection against endotoxin by plasma high density lipoprotein”. Proceedings of the National Academy of Sciences of the United States of America 90 (1993): 12040-12044.
13. Mogensen TH. “Pathogen recognition and inflammatory signaling in innate immune defenses”. Clinical Microbiology Reviews 22 (2009): 240-273.
14. Cani PD., et al. “Metabolic endotoxemia initiates obesity and insulin resistance”. Diabetes 56 (2007): 1761-1772.
15. Hansel B., et al. “Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity”. The Journal of Clinical Endocrinology and Metabolism 89 (2004): 4963-4971.
16. Fox CS., et al. “Predictors of new-onset kidney disease in a community based population”. The Journal of the American Medical Association 7 (2004): 844-850.
17. Hsu CY., et al. “Body mass index and risk of end stage renal disease”. Annals of Internal Medicine 1 (2006): 21-28.
18. Kramer H., et al. “Obesity and prevalent and incident CKD: the hypertension detection and follow-up program”. American Journal of Kidney Diseases 4 (2005): 587-594.
19. Kambham N., et al. “Obesity-related glomerulopathy: an emerging epidemic”. Kidney International 4 (2001): 1498-1509.
20. Praga M., et al. “Clinical features and long term outcome of obesity-associated focal segment glomerulosclerosis”. Nephrology Dialysis Transplantation 9 (2001): 1790-1798.
21. Huang PL. “A comprehensive definition for metabolic syndrome”. Disease Models and Mechanisms 2 (2009): 231-237.
22. Charmandari E., et al. “Pediatric stress: hormonal mediators and human development”. Hormone Research in Paediatrics 4 (2003): 161-179.
23. Pervanidou P and Chrousos GP. “Stress and obesity/metabolic syndromein childhood and adolescence”. The International Journal of Pediatric Obesity 1 (2011): 21-28.
24. Charmandari E., et al. “Endocrinology of the stress response”. Annual Review of Physiology 67 (2005): 259-284.
25. Nader N., et al. “Interactions of the circadian CLOCK system and the HPA axis”. Trends in Endocrinology and Metabolism 5 (2010): 277-286.
26. Charmandari E., et al. “Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man”. Plos One9 (2011): e25612.
27. Onyike CU., et al. “Is obesity associated with major depression?. Results from the Third National Health and Nutrition Examination Survey”. American Journal of Epidemiology12 (2003): 1139-1147.
28. Pervanidou P., et al. “Cortisol profiles, and depressive symptomatology, and body mass index ina clinical population of obese children”. Stress1 (2013): 34-43.
29. Expert panel in integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report”. Pediatrics 5 (2011): S213-S256.
30. World Health Organization. “Health Education and Health Promotion Unit‎. Annual global move for health initiative a concept paper”. World Health Organization (2003).

Citation

Citation: Priyanka Bhateja and Roosy Aulakh. “Obesity and Metabolic Dysregulation in Childhood: A Review”. Acta Scientific Paediatrics 3.6 (2020): 11-14.

Copyright

Copyright: © 2020 Priyanka Bhateja and Roosy Aulakh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.